Sagimet Biosciences Inc. logo

Sagimet Biosciences Inc.

SGMT | NASDAQ
Chart Builder DCF Calculator
$10.96
+$0.16 (+1.48%)
Sep 22, 2026, 9:40 AM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 2M 2M 2M 2M n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a 2M 2M 2M 2M n/a n/a n/a n/a n/a n/a
Operating Income
-52.63M -48.74M -56.89M -64.32M -66.89M -65.55M -54.45M -45.73M -36.28M -32.74M -30.74M -28.66M -28.9M -29.08M -31.06M -23.67M -15.98M -8.74M
Interest Income
-739K 800K 1.43M 6.65M 7.51M 8.44M 8.89M 8.21M 7.02M 4.82M 2.86M 1.74M 862K 727K 553K 360K 142K 6K
Pretax Income
-47.08M -43.51M -51.04M -57.67M -59.38M -57.11M -45.57M -37.52M -29.25M -27.92M -27.88M -26.92M -28.03M -28.35M -30.5M -23.3M -15.84M -8.74M
Net Income
-47.08M -43.51M -51.04M -57.67M -59.38M -57.11M -45.57M -37.52M -29.25M -27.92M -27.88M -26.92M -28.03M -28.35M -30.5M -23.3M -15.84M -8.74M
Selling & General & Admin
17.64M 18.03M 17.84M 17.78M 17.43M 17.03M 16.01M 15.84M 16.09M 14.19M 12.96M 10.69M 7.05M 5.53M 6.14M 4.6M 3.75M 2.88M
Research & Development
34.99M 30.71M 39.05M 46.54M 49.46M 48.52M 38.44M 29.88M 22.19M 20.55M 19.78M 19.97M 21.85M 23.54M 24.92M 19.07M 12.23M 5.86M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
52.63M 48.74M 56.89M 64.32M 66.89M 65.55M 54.45M 45.73M 38.28M 34.74M 32.74M 30.66M 28.9M 29.08M 31.06M 23.67M 15.98M 8.74M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
52.63M 48.74M 56.89M 64.32M 66.89M 65.55M 54.45M 45.73M 38.28M 34.74M 32.74M 30.66M 28.9M 29.08M 31.06M 23.67M 15.98M 8.74M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
53.11M 32.56M 32.52M 32.46M 32.2M 32.2M 32.2M 32.14M 31.91M 29.04M 18.19M 18.19M 22.17M 22.17M 22.17M 22.17M 22.17M 22.17M
Shares Outstanding (Diluted)
53.11M 32.56M 32.52M 32.46M 32.2M 32.2M 32.2M 32.14M 31.91M 29.04M 18.19M 18.19M 22.17M 22.17M 22.17M 22.17M 22.17M 22.17M
EPS (Basic)
-1.28 -1.34 -1.57 -1.78 -1.83 -1.76 -1.43 -1.38 -1.28 -1.34 -1.41 -1.28 -1.27 -1.28 -1.37 -1.05 -0.71 -0.39
EPS (Diluted)
-1.28 -1.34 -1.57 -1.78 -1.83 -1.76 -1.43 -1.38 -1.28 -1.34 -1.41 -1.28 -1.27 -1.28 -1.37 -1.05 -0.71 -0.39
EBITDA
-49.7M -46.14M -53.66M -57.67M -59.38M -57.11M -36.8M -19.28M -11.02M -9.68M -18.41M -19.53M -12.96M -6.04M -8.16M -8.35M -8.57M -8.7M
EBIT
-49.7M -46.14M -53.66M -57.67M -59.38M -57.11M -45.57M -37.52M -29.25M -27.92M -27.88M -26.92M -28.03M -28.35M -30.5M -23.3M -15.84M -8.74M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a 8.77M 18.23M 18.23M 18.23M 9.47M 7.39M 15.07M 22.31M 22.34M 14.96M 7.27M 32K

© 2026 bestshares.com. All rights reserved.